• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将 cBioPortal 癌症基因组学扩展到分子肿瘤委员会平台所面临的挑战和经验。

Challenges and Experiences Extending the cBioPortal for Cancer Genomics to a Molecular Tumor Board Platform.

机构信息

Group for Medical Systems Biology, Lübeck Institute of Experimental Dermatology, Universität zu Lübeck, Germany.

Institute of Medical Bioinformatics and Systems Medicine, Faculty of Medicine and Medical Center - University of Freiburg, Freiburg, Germany.

出版信息

Stud Health Technol Inform. 2021 Nov 18;287:139-143. doi: 10.3233/SHTI210833.

DOI:10.3233/SHTI210833
PMID:34795098
Abstract

In Molecular Tumor Boards (MTBs), therapy recommendations for cancer patients are discussed. To aid decision-making based on the patient's molecular profile, the research platform cBioPortal was extended based on users' requirements. Additionally, a comprehensive dockerized workflow was developed to support the deployment of cBioPortal and connected services. In this work, we present the challenges and experiences of nearly two years of implementing and deploying an MTB platform based on cBioPortal and compare those to findings of a previous study.

摘要

在分子肿瘤委员会 (MTB) 中,会讨论癌症患者的治疗建议。为了根据患者的分子图谱辅助决策,我们根据用户的需求扩展了研究平台 cBioPortal。此外,还开发了一个全面的 Docker 化工作流程来支持 cBioPortal 和相关服务的部署。在这项工作中,我们展示了近两年来实施和部署基于 cBioPortal 的 MTB 平台所面临的挑战和经验,并与之前的一项研究的结果进行了比较。

相似文献

1
Challenges and Experiences Extending the cBioPortal for Cancer Genomics to a Molecular Tumor Board Platform.将 cBioPortal 癌症基因组学扩展到分子肿瘤委员会平台所面临的挑战和经验。
Stud Health Technol Inform. 2021 Nov 18;287:139-143. doi: 10.3233/SHTI210833.
2
Extending cBioPortal for Therapy Recommendation Documentation in Molecular Tumor Boards: Development and Usability Study.扩展cBioPortal用于分子肿瘤委员会中的治疗推荐文档记录:开发与可用性研究
JMIR Med Inform. 2023 Dec 11;11:e50017. doi: 10.2196/50017.
3
Requirements Analysis and Specification for a Molecular Tumor Board Platform Based on cBioPortal.基于cBioPortal的分子肿瘤专家委员会平台的需求分析与规范
Diagnostics (Basel). 2020 Feb 10;10(2):93. doi: 10.3390/diagnostics10020093.
4
Developing New Analysis Functions for a Translational Research Platform: Extending the cBioPortal for Cancer Genomics.为转化研究平台开发新的分析功能:扩展癌症基因组学的cBioPortal
Stud Health Technol Inform. 2019;258:46-50.
5
FhirSpark - Implementing a Mediation Layer to Bring FHIR to the cBioPortal for Cancer Genomics.FhirSpark——实现一个中介层,将FHIR引入用于癌症基因组学的cBioPortal。
Stud Health Technol Inform. 2021 May 27;281:303-307. doi: 10.3233/SHTI210169.
6
cbpManager: a web application to streamline the integration of clinical and genomic data in cBioPortal to support the Molecular Tumor Board.cbpManager:一个简化 cBioPortal 中临床和基因组数据集成的 Web 应用程序,以支持分子肿瘤委员会。
BMC Med Inform Decis Mak. 2021 Dec 20;21(1):358. doi: 10.1186/s12911-021-01719-z.
7
Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations.荷兰分子肿瘤委员会的多中心比较:定义、组成、方法及靶向治疗建议
Oncologist. 2021 Aug;26(8):e1347-e1358. doi: 10.1002/onco.13580. Epub 2020 Nov 10.
8
Molecular Tumor Boards: current practice and future needs.分子肿瘤委员会:当前的实践和未来的需求。
Ann Oncol. 2017 Dec 1;28(12):3070-3075. doi: 10.1093/annonc/mdx528.
9
Development and validation of ACTE-MTB: A tool to systematically assess the maturity of molecular tumor boards.ACTE-MTB的开发与验证:一种系统评估分子肿瘤委员会成熟度的工具。
PLoS One. 2022 May 13;17(5):e0268477. doi: 10.1371/journal.pone.0268477. eCollection 2022.
10
Automatic Integration of Clinical and Genetic Data Using cBioPortal.利用 cBioPortal 实现临床与基因数据的自动整合。
Stud Health Technol Inform. 2022 Jun 6;290:799-803. doi: 10.3233/SHTI220189.

引用本文的文献

1
User-centered design approach to visualize PROMs for molecular tumor boards.以用户为中心的设计方法,用于为分子肿瘤学专家组可视化患者报告结局测量(PROMs)。
NPJ Precis Oncol. 2025 Aug 5;9(1):273. doi: 10.1038/s41698-025-01061-x.
2
Key genes altered in glioblastoma based on bioinformatics (Review).基于生物信息学的胶质母细胞瘤中改变的关键基因(综述)
Oncol Lett. 2025 Mar 24;29(5):243. doi: 10.3892/ol.2025.14989. eCollection 2025 May.
3
IP6K2 mutations as a novel mechanism of resistance to oncolytic virus therapy.IP6K2突变作为溶瘤病毒治疗耐药性的一种新机制。
J Transl Med. 2025 Mar 12;23(1):311. doi: 10.1186/s12967-025-06265-0.
4
A novel glycolysis-related gene signature for predicting prognosis and immunotherapy efficacy in breast cancer.一种用于预测乳腺癌预后和免疫治疗疗效的新型糖酵解相关基因特征。
Front Immunol. 2025 Feb 19;16:1512859. doi: 10.3389/fimmu.2025.1512859. eCollection 2025.
5
Empowering personalized oncology: evolution of digital support and visualization tools for molecular tumor boards.助力个性化肿瘤学:分子肿瘤委员会数字支持与可视化工具的发展
BMC Med Inform Decis Mak. 2025 Jan 16;25(1):29. doi: 10.1186/s12911-024-02821-8.
6
Clinical bioinformatics desiderata for molecular tumor boards.分子肿瘤委员会的临床生物信息学需求。
Brief Bioinform. 2024 Jul 25;25(5). doi: 10.1093/bib/bbae447.
7
Data Visualization Support for Tumor Boards and Clinical Oncology: Protocol for a Scoping Review.肿瘤病例讨论会和临床肿瘤学的数据可视化支持:一项范围综述的方案
JMIR Res Protoc. 2024 Mar 5;13:e53627. doi: 10.2196/53627.
8
Extending cBioPortal for Therapy Recommendation Documentation in Molecular Tumor Boards: Development and Usability Study.扩展cBioPortal用于分子肿瘤委员会中的治疗推荐文档记录:开发与可用性研究
JMIR Med Inform. 2023 Dec 11;11:e50017. doi: 10.2196/50017.
9
Ten Topics to Get Started in Medical Informatics Research.医学信息学研究入门的十个主题
J Med Internet Res. 2023 Jul 24;25:e45948. doi: 10.2196/45948.
10
MIRACUM-Pipe: An Adaptable Pipeline for Next-Generation Sequencing Analysis, Reporting, and Visualization for Clinical Decision Making.MIRACUM-Pipe:一种适用于下一代测序分析、报告及可视化以支持临床决策的流程。
Cancers (Basel). 2023 Jul 1;15(13):3456. doi: 10.3390/cancers15133456.